Target intelligence / Profile preview

Pro-inflammatory cytokine networks and mediators

Molecular classification
Cytokine, Signaling molecule, Protein family
01

Overview

Pro-inflammatory cytokine networks and mediators comprise a diverse group of signaling proteins, including Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), that orchestrate the immune system's response to injury and infection (StatPearls, 2023: https://www.ncbi.nlm.nih.gov/books/NBK545230/). These molecules are primarily secreted by immune cells like macrophages and lymphocytes, acting to promote inflammation and recruit further immune cells to sites of damage (Nature Reviews Immunology, 2018: https://www.nature.com/articles/nri.2017.125). In a healthy state, these networks are tightly regulated; however, their chronic overproduction is central to the pathogenesis of various inflammatory conditions, including rheumatoid arthritis and Crohn's disease (Frontiers in Immunology, 2021: https://www.frontiersin.org/articles/10.3389/fimmu.2021.650121/full). Pharmacological intervention typically targets specific nodes within these networks, such as using monoclonal antibodies to neutralize TNF-α or IL-6, or small molecule inhibitors to block downstream signaling pathways like the JAK-STAT pathway (Journal of Clinical Investigation, 2017: https://www.jci.org/articles/view/93248). While highly effective in reducing disease activity, modulating these networks carries risks of systemic immunosuppression and increased susceptibility to opportunistic infections (The Lancet, 2019: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(19)30001-9/fulltext).

Other names
Inflammatory mediatorsPro-inflammatory cytokinesCytokine signaling networkInflammatory cascade
02

Mechanism of action

Drugs targeting these networks function by neutralizing soluble cytokines (e.g., TNF-alpha inhibitors), competitively blocking cytokine receptors (e.g., IL-1 receptor antagonists), or inhibiting intracellular signaling transducers like Janus kinases (JAKs) to prevent the transcription of inflammatory genes (Nature Reviews Drug Discovery, 2022: https://www.nature.com/articles/s41573-021-00356-x).

03

Biological functions

Immune responseInflammationSignal transductionCell-to-cell communicationApoptosis induction
04

Disease associations

InflammationAutoimmune diseaseSepsisCancerNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Increased risk of serious infections (e.g., tuberculosis, fungal infections)Reactivation of latent infectionsPotential risk of malignancies such as lymphomaInjection site or infusion-related reactionsNeutropenia and cytopenias (The Lancet, 2019: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(19)30001-9/fulltext)
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6) levelsTumor Necrosis Factor-alpha (TNF-α) levelsErythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Pro-inflammatory cytokine networks and mediators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro-inflammatory cytokine networks and mediators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call